Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer.

Gorovets, Daniel; Hopkins, Margaret; Kollmeier, Marisa; Moore, Assaf; Goel, Arun; Shasha, Daniel; Brennan, Victoria; McBride, Sean; Cohen, Gilad; Damato, Antonio L; Zelefsky, Michael J

Gorovets, Daniel; Hopkins, Margaret; Kollmeier, Marisa; Moore, Assaf; Goel, Arun; Shasha, Daniel; Brennan, Victoria; McBride, Sean; Cohen, Gilad; Damato, Antonio L; Zelefsky, Michael J.

Affiliation

Gorovets D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: gorovetd@mskcc.org.
Hopkins M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Kollmeier M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Moore A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Goel A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Shasha D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Brennan V; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
McBride S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Cohen G; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
Damato AL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Brachytherapy ; 20(6): 1099-1106, 2021.

Article in En | MEDLINE | ID: mdl-34588146

Subject(s)

Brachytherapy; Prostatic Neoplasms; Androgen Antagonists; Brachytherapy/methods; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms/radiotherapy; Radiation Dose Hypofractionation

Key words

CTCAE, Common Terminology Criteria for Adverse Events; CTV, clinical target volume; EBRT, external beam radiation therapy; EPE, extra-prostatic extension; EPIC, Expanded Prostate Cancer Index Composite; GI, gastrointestinal; GU, genitourinary; HDR, high-dose rate; High dose rate brachytherapy; IMRT, intensity-modulated radiation therapy; IPSS, International Prostate Symptom Score; LDR, low-dose rate; NCCN, National Comprehensive Cancer Network; OARS, organs at risk; PET, positron emission tomography; PFS, progression-free survival; PRO, patient-reported outcomes; PSA, prostate-specific antigen; PSMA, prostate-specific membrane antigen; PTV, planning target volume; Prostate cancer; SBRT, stereotactic body radiation therapy; Stereotactic radiosurgery; Toxicity. Abbreviations: ADT, androgen deprivation therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: Brachytherapy Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google